Cipher Pharma (CPHR) Tops Q4 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. SPOT
6. FIX
7. BE
8. WCN
9. AXP
10. NDAQ

Go back to Cipher Pharma (CPHR) Tops Q4 EPS by 8c

Cipher Pharmaceuticals Reports 2015 Financial Results

February 24, 2016 7:07 AM EST

Q4 revenue up 30%, Company significantly advances strategic plans to build adermatology growth company

MISSISSAUGA, ON, Feb. 24, 2016 /PRNewswire/ - Cipher Pharmaceuticals Inc. (NASDAQ:CPHR; TSX: CPH) ("Cipher" or "the Company") today announced its financial and operational results for the three and twelve months ended December 31, 2015.

"In 2015 we made major strides to transform Cipher from a royalty business into an integrated dermatology growth company with a solid commercial foundation in the U.S. and Canada, a portfolio of currently marketed products, and a robust pipeline of... More